A Randomized Controlled Trial to Investigate The Role of Adjuvant Inhalable Sodium Bicarbonate Solution 8.4% in Treatment of COVID-19

Summary

The aim of the study is to investigate the role of SB 8.4% as adjuvant therapy in the treatment of COVID- 19 patients proved to be RT-PCR positive (mild, moderate and severe).

Timeline

Start

2021-09-01

Primary completion

2022-03-01

Completion

2022-03-01

Publications

• El-Badrawy MK, Elmorsey RA, Elhosiny MM, Shehta M, El-Hadidy TA, Abdelwahab IE, El-Badrawy A, Shokeir AA. Efficacy and Safety of Nebulized Sodium Bicarbonate in Adults with COVID-19 (SODIC): A Randomized, Single-Center, Double-Blinded, Controlled Trial. Curr Ther Res Clin Exp. 2025 May 22;103:100801. doi: 10.1016/j.curtheres.2025.100801. eCollection 2025.

Drugs

Indications